HLA-Cw group 1 ligands for KIR increase susceptibility to invasive cervical cancer

Immunogenetics

Volumn 62, Issue 11-12, 2010, Pages 761-765

  Martin, Maureen P ^a   Borecki, Ingrid B ^b   Zhang, Zhengyan ^b   Nguyen, Loan ^b   Ma, Duanduan ^b   Gao, Xiaojiang ^a   Qi, Ying ^a   Carrington, Mary ^a,c   Rader, Janet S ^b,d  

^a SAIC FREDERICK INC   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HARVARD UNIVERSITY   (United States)

^d MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Cervical neoplasia; HLA; HPV; KIR

Indexed keywords

ASPARAGINE; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; LIGAND;

ADULT; ARTICLE; CANCER INVASION; CONTROLLED STUDY; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; HAPLOTYPE; HLA SYSTEM; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN TISSUE; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA IN SITU;

ADULT; FEMALE; HLA-C ANTIGENS; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, KIR; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPES;

EID: 78649315844     PISSN: 00937711     EISSN: 14321211     Source Type: Journal    
DOI: 10.1007/s00251-010-0477-5     Document Type: Article

References (33)

1. L Arnheim J Dillner CB Sanjeevi 2005 A population-based cohort study of KIR genes and genotypes in relation to cervical intraepithelial neoplasia Tissue Antigens 65 252 259 1:CAS:528:DC%2BD2MXivFars7s%3D 10.1111/j.1399-0039.2005. 00359.x 15730517 (Pubitemid 40342431)
2. F Balkwill KA Charles A Mantovani 2005 Smoldering and polarized inflammation in the initiation and promotion of malignant disease Cancer Cell 7 211 217 1:CAS:528:DC%2BD2MXivFCqurk%3D 10.1016/j.ccr.2005.02.013 15766659 (Pubitemid 40568680)
3. S Belinson JS Smith E Myers A Olshan J Belinson R Pretorius YL Qiao K Hartmann 2008 Descriptive evidence that risk profiles for cervical intraepithelial neoplasia 1, 2, and 3 are unique Cancer Epidemiol Biomarkers Prev 17 2350 2355 10.1158/1055-9965.EPI-08-0004 18768503
4. FX Bosch S de Sanjose 2007 The epidemiology of human papillomavirus infection and cervical cancer Dis Markers 23 213 227 17627057
5. LR Cardon LJ Palmer 2003 Population stratification and spurious allelic association Lancet 361 598 604 10.1016/S0140-6736(03)12520-2 12598158 (Pubitemid 36207482)
6. M Carrington MP Martin J van Bergen 2008 KIR-HLA intercourse in HIV disease Trends Microbiol 16 620 627 1:CAS:528:DC%2BD1cXhsVGgtrvN 10.1016/j.tim.2008.09.002 18976921
7. M Carrington S Wang MP Martin X Gao M Schiffman J Cheng R Herrero AC Rodriguez R Kurman R Mortel P Schwartz A Glass A Hildesheim 2005 Hierarchy of resistance to cervical neoplasia mediated by combinations of killer immunoglobulin-like receptor and human leukocyte antigen loci J Exp Med 201 1069 1075 1:CAS:528:DC%2BD2MXjtFWlsrc%3D 10.1084/jem.20042158 15809352 (Pubitemid 40524675)
8. AK Chaturvedi MM Madeleine RJ Biggar EA Engels 2009 Risk of human papillomavirus-associated cancers among persons with AIDS J Natl Cancer Inst 101 1120 1130 10.1093/jnci/djp205 19648510
9. D Clayton 1999 A generalization of the transmission/disequilibrium test for uncertain-haplotype transmission Am J Hum Genet 65 1170 1177 1:STN:280:DC%2BD3cvnsFeksQ%3D%3D 10.1086/302577 10486336 (Pubitemid 30462974)
10. D Clayton H Jones 1999 Transmission/disequilibrium tests for extended marker haplotypes Am J Hum Genet 65 1161 1169 1:STN:280:DC%2BD3cvnsFeksA%3D%3D 10.1086/302566 10486335 (Pubitemid 30462973)
11. Clayton J, Lonjou C (1997) Allele and haplotype frequencies for HLA loci in various ethnic groups. In: Charron D (ed) Genetic Diversity of HLA. Functional and Medical Implication, pp. 668-820. Medical and Scientific International, Paris
12. N Coleman HD Birley AM Renton NF Hanna BK Ryait M Byrne D Taylor-Robinson MA Stanley 1994 Immunological events in regressing genital warts Am J Clin Pathol 102 768 774 1:STN:280:DyaK2M7gtVWnsg%3D%3D 7801889
13. KE de Visser A Eichten LM Coussens 2006 Paradoxical roles of the immune system during cancer development Nat Rev Cancer 6 24 37 10.1038/nrc1782 16397525 (Pubitemid 43053650)
14. H De Vuyst F Lillo N Broutet JS Smith 2008 HIV, human papillomavirus, and cervical neoplasia and cancer in the era of highly active antiretroviral therapy Eur J Cancer Prev 17 545 554 10.1097/CEJ.0b013e3282f75ea1 18941376
15. J Doorbar 2006 Molecular biology of human papillomavirus infection and cervical cancer Clin Sci (Lond) 110 525 541 1:CAS:528:DC%2BD28XjtlCgs7k%3D 10.1042/CS20050369 (Pubitemid 43736116)
16. J Fellay KV Shianna D Ge S Colombo B Ledergerber M Weale K Zhang C Gumbs A Castagna A Cossarizza A Cozzi-Lepri A De Luca P Easterbrook P Francioli S Mallal J Martinez-Picado JM Miro N Obel JP Smith J Wyniger P Descombes SE Antonarakis NL Letvin AJ McMichael BF Haynes A Telenti DB Goldstein 2007 A whole-genome association study of major determinants for host control of HIV-1 Science 317 944 947 1:CAS:528:DC%2BD2sXptVaju7g%3D 10.1126/science.1143767 17641165 (Pubitemid 47301321)
17. ML Freedman D Reich KL Penney GJ McDonald AA Mignault N Patterson SB Gabriel EJ Topol JW Smoller CN Pato MT Pato TL Petryshen LN Kolonel ES Lander P Sklar B Henderson JN Hirschhorn D Altshuler 2004 Assessing the impact of population stratification on genetic association studies Nat Genet 36 388 393 1:CAS:528:DC%2BD2cXis1aht7s%3D 10.1038/ng1333 15052270 (Pubitemid 38437262)
18. IARC Working Group (1995) Human papillomaviruses. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans 64:1-378
19. LA Koopman WE Corver AR van der Slik MJ Giphart GJ Fleuren 2000 Multiple genetic alterations cause frequent and heterogeneous human histocompatibility leukocyte antigen class I loss in cervical cancer J Exp Med 191 961 976 1:CAS:528:DC%2BD3cXitVehsrs%3D 10.1084/jem.191.6.961 10727458
20. J Koshiol L Lindsay JM Pimenta C Poole D Jenkins JS Smith 2008 Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis Am J Epidemiol 168 123 137 10.1093/aje/kwn036 18483125 (Pubitemid 351951589)
21. S Kulkarni MP Martin M Carrington 2008 The Yin and Yang of HLA and KIR in human disease Semin Immunol 20 343 352 1:CAS:528:DC%2BD1cXhsVCgtr3F 10.1016/j.smim.2008.06.003 18635379
22. J Li DS Gerhard Z Zhang PC Huettner J Wright L Nguyen D Lu JS Rader 2003 Denaturing high-performance liquid chromatography for detecting and typing genital human papillomavirus J Clin Microbiol 41 5563 5571 1:CAS:528: DC%2BD2cXjtF2jug%3D%3D 10.1128/JCM.41.12.5563-5571.2003 14662941 (Pubitemid 37543246)
23. EO Long S Rajagopalan 2000 HLA class I recognition by killer cell Ig-like receptors Semin Immunol 12 101 108 1:CAS:528:DC%2BD3cXitl2qs78%3D 10.1006/smim.2000.0212 10764618 (Pubitemid 30199274)
24. MP Martin M Carrington 2008 KIR locus polymorphisms: genotyping and disease association analysis Methods Mol Biol 415 49 64 1:CAS:528: DC%2BD2sXhsVGiu7zP 10.1007/978-1-59745-570-1-3 18370147
25. RJ Neuman PC Huettner L Li ER Mardis BF Duffy RK Wilson JS Rader 2000 Association between DQB1 and cervical cancer in patients with human papillomavirus and family controls Obstet Gynecol 95 134 140 1:CAS:528:DC%2BD3cXnvF2q 10.1016/S0029-7844(99)00501-3 10636516 (Pubitemid 30001643)
26. H Reyburn O Mandelboim M Vales-Gomez EG Sheu L Pazmany DM Davis JL Strominger 1997 Human NK cells: their ligands, receptors and functions Immunol Rev 155 119 125 1:CAS:528:DyaK2sXhsV2hsLo%3D 10.1111/j.1600-065X.1997.tb00944.x 9059887 (Pubitemid 27076063)
27. BE Stranger MS Forrest AG Clark MJ Minichiello S Deutsch R Lyle S Hunt B Kahl SE Antonarakis S Tavare P Deloukas ET Dermitzakis 2005 Genome-wide associations of gene expression variation in humans PLoS Genet 1 e78 10.1371/journal.pgen.0010078 16362079
28. BE Stranger AC Nica MS Forrest A Dimas CP Bird C Beazley CE Ingle M Dunning P Flicek D Koller S Montgomery S Tavare P Deloukas ET Dermitzakis 2007 Population genomics of human gene expression Nat Genet 39 1217 1224 1:CAS:528:DC%2BD2sXhtV2isL7N 10.1038/ng2142 17873874 (Pubitemid 47482691)
29. R Thomas R Apps Y Qi X Gao V Male C O'HUigin G O'Connor D Ge J Fellay JN Martin J Margolick JJ Goedert S Buchbinder GD Kirk MP Martin A Telenti SG Deeks BD Walker D Goldstein DW McVicar A Moffett M Carrington 2009 HLA-C cell surface expression and control of HIV/AIDS correlate with a variant upstream of HLA-C Nat Genet 41 1290 1294 1:CAS:528:DC%2BD1MXhsVGlurvL 10.1038/ng.486 19935663
30. SS Wang A Hildesheim X Gao M Schiffman R Herrero MC Bratti ME Sherman WA Barnes MD Greenberg L McGowan R Mortel PE Schwartz RJ Zaino AG Glass RD Burk P Karacki M Carrington 2002 Comprehensive analysis of human leukocyte antigen class I alleles and cervical neoplasia in 3 epidemiologic studies J Infect Dis 186 598 605 1:CAS:528:DC%2BD38XnsVSltb0%3D 10.1086/342295 12195346 (Pubitemid 34925531)
31. SS Wang A Hildesheim X Gao M Schiffman R Herrero MC Bratti ME Sherman WA Barnes MD Greenberg L McGowan R Mortel PE Schwartz RJ Zaino AG Glass RD Burk P Karacki M Carrington 2002 Human leukocyte antigen class I alleles and cervical neoplasia: no heterozygote advantage Cancer Epidemiol Biomarkers Prev 11 419 420 11927505
32. SS Wang CM Wheeler A Hildesheim M Schiffman R Herrero MC Bratti ME Sherman M Alfaro ML Hutchinson J Morales A Lorincz RD Burk M Carrington HA Erlich RJ Apple 2001 Human leukocyte antigen class I and II alleles and risk of cervical neoplasia: results from a population-based study in Costa Rica J Infect Dis 184 1310 1314 1:CAS:528:DC%2BD3MXpt1WhsLo%3D 10.1086/324209 11679920 (Pubitemid 33055576)
33. Z Zhang I Borecki L Nguyen D Ma K Smith PC Huettner DG Mutch TJ Herzog RK Gibb MA Powell PW Grigsby LS Massad E Hernandez PL Judson EM Swisher S Crowder J Li DS Gerhard JS Rader 2007 CD83 gene polymorphisms increase susceptibility to human invasive cervical cancer Cancer Res 67 11202 11208 1:CAS:528: DC%2BD2sXhtlyiurbP 10.1158/0008-5472.CAN-07-2677 18056445 (Pubitemid 350248545)